Improving Depression Care for Elders: Coordinating Center

University of California, Los Angeles1,801 enrolled

Overview

Purpose: To determine the effectiveness of the Improving Mood-Promoting Access to Collaborative Treatment(IMPACT) collaborative care management program for late-life depression.

This study tested an organized method of delivering care for late life depression in primary care. Specifically, the investigators evaluated the effectiveness of this intervention as compared to 'care as usual'. The investigators studied the effect of the intervention on clinical outcomes such as depressive symptoms, functional status, health related quality of life. They also determined the cost-effectiveness of the intervention compared to care as usual.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

1,801

Conditions

Major Depression Dysthymic Disorder Both Major Depression and Dysthymic Disorder

Interventions

IMPACTOTHER

IMPACT is a collaborative care management program for late-life depression

Eligibility

Sex: ALLMin age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Major depression or dysthymia as diagnosed by a structured diagnostic interview. * Patient plans to receive primary care at the study clinic for the next year. Exclusion Criteria: * Age under 60. * Current symptoms or history of psychosis or mania as determined by structured diagnostic interview. * Cognitive impairment as defined by a score less than 23 on a Mini Mental Status Examination. * Terminal illness - defined as having a life expectancy of less than 6 months. * Active alcohol abuse as determined by a screening interview. * High suicide risk as determined by current plan for suicide or a history of more than 3 prior suicide attempts in the past 10 years.

Outcomes

Primary Outcomes

Severity of depression symptoms

Severity measured by the 21-item Hopkins Symptom Checklist.

Secondary Outcomes

Functioning

measured by the Sheehan Health-Related Functioning Index

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.